CPIM
AZN icon

Columbia Partners Investment Management’s AstraZeneca AZN Stock Holding History

Columbia Partners Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-67,980
Closed -$3.83M – 337
2016
Q1 		$3.83M Sell
67,980
-60,325
-47% -$3.62M 0.27% 123
2015
Q4 		$8.71M Sell
128,305
-11,420
-8% -$749K 0.6% 53
2015
Q3 		$8.89M Buy
139,725
+2,113
+2% +$139K 0.62% 51
2015
Q2 		$8.77M Buy
137,612
+56,854
+70% +$3.89M 0.54% 75
2015
Q1 		$5.53M Buy
80,758
+11,468
+17% +$797K 0.29% 125
2014
Q4 		$4.88M Sell
69,290
-2,172
-3% -$156K 0.25% 130
2014
Q3 		$5.11M Buy
71,462
+15,098
+27% +$1.11M 0.26% 129
2014
Q2 		$4.19M Buy
56,364
+25,236
+81% +$1.82M 0.19% 155
2014
Q1 		$2.02M Buy
31,128
+1,106
+4% +$71.4K 0.09% 210
2013
Q4 		$1.78M Buy
30,022
+2,010
+7% +$109K 0.08% 207
2013
Q3 		$1.45M Buy
28,012
+3,520
+14% +$177K 0.06% 224
2013
Q2 		$1.16M Buy
+24,492
New +$1.25M 0.05% 239

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Columbia Partners Investment Management's AZN Position: Q2 2016 in Review

Columbia Partners Investment Management sold out of AstraZeneca (AZN) in Q2 2016, closing a stake of 67,980 shares — an estimated $3.83M sold.

Columbia Partners Investment Management first reported a position in AZN in Q2 2013 and held it in 12 quarters. The position peaked at $8.89M in Q3 2015. 398 funds tracked by Wall St. Rank hold AZN as of Q2 2016.

  • Columbia Partners Investment Management reported no remaining AstraZeneca position as of Q2 2016 after selling out during the quarter.
  • Columbia Partners Investment Management sold 67,980 AstraZeneca shares in Q2 2016, an estimated $3.83M.
  • Columbia Partners Investment Management first reported a position in AstraZeneca in Q2 2013 and held it in 12 quarters.
  • Columbia Partners Investment Management's AstraZeneca position peaked at $8.89M in Q3 2015.
  • 398 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2016.

Based on Columbia Partners Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.